A 68-year-old woman is reviewed after a DEXA scan shows a T-score of -2.8 at the femoral neck. She has no history of fragility fractures. She takes levothyroxine for hypothyroidism but has no other significant medical history. According to NICE guidance (NG143), what is the most appropriate first-line pharmacological treatment to reduce fracture risk?